Ameriprise Financial Inc. Purchases 194,597 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)

Ameriprise Financial Inc. raised its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 150.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 324,261 shares of the company's stock after buying an additional 194,597 shares during the period. Ameriprise Financial Inc. owned 0.70% of Pacira BioSciences worth $6,109,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the stock. Nisa Investment Advisors LLC increased its stake in shares of Pacira BioSciences by 495.3% in the fourth quarter. Nisa Investment Advisors LLC now owns 3,304 shares of the company's stock worth $62,000 after purchasing an additional 2,749 shares during the period. Gagnon Securities LLC increased its stake in shares of Pacira BioSciences by 4.8% in the fourth quarter. Gagnon Securities LLC now owns 321,743 shares of the company's stock worth $6,062,000 after purchasing an additional 14,800 shares during the period. China Universal Asset Management Co. Ltd. increased its stake in shares of Pacira BioSciences by 10.3% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,790 shares of the company's stock worth $184,000 after purchasing an additional 918 shares during the period. Caitlin John LLC increased its stake in shares of Pacira BioSciences by 1,850.0% in the fourth quarter. Caitlin John LLC now owns 1,872 shares of the company's stock worth $35,000 after purchasing an additional 1,776 shares during the period. Finally, Empowered Funds LLC increased its stake in shares of Pacira BioSciences by 5.1% in the fourth quarter. Empowered Funds LLC now owns 229,485 shares of the company's stock worth $4,323,000 after purchasing an additional 11,149 shares during the period. 99.73% of the stock is currently owned by institutional investors.

Pacira BioSciences Price Performance

Shares of NASDAQ:PCRX traded up $0.37 during trading on Thursday, reaching $25.93. The stock had a trading volume of 574,241 shares, compared to its average volume of 974,536. Pacira BioSciences, Inc. has a 52 week low of $11.16 and a 52 week high of $31.64. The business's 50-day moving average price is $25.33 and its 200 day moving average price is $22.92. The company has a debt-to-equity ratio of 0.51, a current ratio of 2.25 and a quick ratio of 1.89. The stock has a market capitalization of $1.20 billion, a PE ratio of -12.77 and a beta of 0.56.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on PCRX shares. Truist Financial raised Pacira BioSciences from a "sell" rating to a "hold" rating and lifted their target price for the stock from $8.00 to $25.00 in a research report on Thursday, January 30th. HC Wainwright lifted their target price on Pacira BioSciences from $48.00 to $65.00 and gave the stock a "buy" rating in a research report on Tuesday, April 8th. Needham & Company LLC decreased their target price on Pacira BioSciences from $32.00 to $30.00 and set a "buy" rating on the stock in a research report on Friday, May 9th. Finally, Barclays lifted their price objective on Pacira BioSciences from $17.00 to $24.00 and gave the company an "overweight" rating in a report on Friday, February 28th. One research analyst has rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $26.44.

Pacira BioSciences Company Profile

Pacira Biosciences, Inc is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients' journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Tampa, FL.